Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology

Clinical trial NCT03703089 · UNKNOWN

Trial details

NCT number: NCT03703089
Sponsor: Benaroya Research Institute
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2018-05-01
Primary completion: 2022-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.